SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005093
Filing Date
2022-03-31
Accepted
2022-03-30 20:28:45
Documents
3
Period of Report
2022-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amlx-q4-earnings-8k.htm 8-K 51370
2 EX-99.1 amlx-ex99_1.htm EX-99.1 143106
3 GRAPHIC img212534189_0.jpg GRAPHIC 631
  Complete submission text file 0000950170-22-005093.txt   196592
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41199 | Film No.: 22788664
SIC: 2834 Pharmaceutical Preparations